Molecular signature linked to acquired resistance to cisplatin in esophageal cancer cells-Reference-Cited by-同舟云学术

Molecular signature linked to acquired resistance to cisplatin in esophageal cancer cells

Published:2004-07 Issue:1 Volume:211 Page:69-78
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Toshimitsu Hiroaki,Hashimoto Kiichiro,Tangoku Akira,Iizuka Norio,Yamamoto Kohtaro,Kawauchi Shigeto,oga Atsunori,Furuya Tomoko,Oka Masaaki,Sasaki Kohsuke

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference58 articles.

1. Combined modality therapy in the treatment of esophageal cancer;Ilson;Semin. Oncol.,1994

2. The nm23-H1 gene as a predictor of sensitivity to chemotherapeutic agents in oesophageal squamous cell carcinoma;Iizuka;Br. J. Cancer,1999

3. Preoperative chemotherapy, surgical resection, and selective postoperative therapy for squamous cell carcinoma of the esophagus;Hilgenberg;Ann. Thorac. Surg.,1988

4. Effects of preoperative chemotherapy on metastatic lymph nodes in esophageal squamous cell carcinoma;Tsuchiya;Dis. Esophagus,2002

5. Cisplatin: mode of cytotoxic action and molecular basis of resistance;Siddik;Oncogene,2003

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive landscape and future perspectives of non-coding RNAs in esophageal squamous cell carcinoma, a bibliometric analysis from 2008 to 2023;Pathology and Oncology Research;2024-02-21

2. Systematic review of comparative transcriptomic studies of cellular resistance to genotoxic stress;Mutation Research/Reviews in Mutation Research;2023-07

3. Long non-coding RNA NORAD/miR-224-3p/MTDH axis contributes to CDDP resistance of esophageal squamous cell carcinoma by promoting nuclear accumulation of β-catenin;Molecular Cancer;2021-12

4. CircRNA-DOPEY2 enhances the chemosensitivity of esophageal cancer cells by inhibiting CPEB4-mediated Mcl-1 translation;Journal of Experimental & Clinical Cancer Research;2021-11-15

5. Molecular markers associated with the outcome of tamoxifen treatment in estrogen receptor-positive breast cancer patients: scoping review and in silico analysis;Discover Oncology;2021-10-01